News
Media
All VideosMedical World NewsPodcastsWeekly RecapCure ConnectionsInsightsSpecial ReportNeurologyLive Peer ExchangeMedcastPeers & PerspectivesRoundtable DiscussionsShows & Podcasts
Conferences
Conference CoverageConference Listing
CME/CE
More
Partners
Publications
NeurologyLiveBridging the GapsInternational Journal of MS Care
Resources
Expert AuthorsFDA NewsFeaturesFellows' CornerFuture Leaders in NeurologyGiants of Multiple SclerosisInteractive ToolsJob BoardLive EventsNeurology ResourcesSponsoredVirtual Events

Subscribe

  • News
  • Media
  • Conferences
  • CME/CE
  • Partners
  • Publications
  • Resources
  • Subscribe
  • Dementia and Alzheimer Disease
  • Epilepsy
  • Genetic Disorders
  • Headache and Migraine
    • Migraine
  • MS and Demyelinating Disorders
    • NMOSD
    • Multiple Sclerosis
  • Movement Disorders
    • Parkinson Disease
    • Dyskinesia
  • Neuromuscular
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Muscular Dystrophy
    • Ataxia
  • Rare Diseases
  • Sleep Disorders
    • Narcolepsy
    • Insomnia
  • Stroke
Spotlight -
Expert Authors|
FDA News|
Upcoming Live Events|
AANEM 2025|
AES 2025|
NSGC 2025
Advertisement

Authors

Susanna M. Zuurbier, MD, PhD
Latest Article

Understanding Cerebral Venous Thrombosis: Rare But Sometimes Fatal

6 years ago

The prognosis of cerebral venous thrombosis (CVT) is favorable compared with other types of stroke: almost 80% of patients with CVT recover without functional disability. Nevertheless, 5% to 10% of patients die in the acute phase.

Jonathan M. Coutinho, MD, PhD
Latest Article

Understanding Cerebral Venous Thrombosis: Rare But Sometimes Fatal

6 years ago

The prognosis of cerebral venous thrombosis (CVT) is favorable compared with other types of stroke: almost 80% of patients with CVT recover without functional disability. Nevertheless, 5% to 10% of patients die in the acute phase.

Laura C. Spetlz, MD
Latest Article

Case Report: New Onset Paroxysmal Episodes in an Infant

6 years ago

A newborn presents with new onset episodes of lateral gaze deviation with extremity stiffening.

Tori Rodriguez, MA
Latest Article

Closing the Treatment Gap in Progressive MS

5 years ago

New biomarkers of disease activity may help better vet investigational therapies aimed at slowing the insidious neurodegeneration seen in primary progressive multiple sclerosis.

Lauren Speltz, MD
Latest Article

Cyclic Vomiting, Incontinence in a Young Boy

6 years ago

An 8 year old boy with genetically confirmed neurofibromatosis type 1 presents with first generalized seizure.

Advertisement
Advertisement

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

1

FDA Approves Generic Glatiramer Acetate Injection for Multiple Sclerosis Treatment

2

FDA Action Update, December 2025: Acceptance, Approval, and Clearance

3

A Clinical Review of the 2025 Neuromyelitis Optica Spectrum Disorder Guidelines

4

AI Model Distinguishes EDSS Subgroup Patterns in Multiple Sclerosis, Study Shows

5

Overviewing 2026 MDA Conference Priorities and Agenda: Angela Lek, PhD

  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us